Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta
about
sameAs
High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouseEvolutionary origins of insulin resistance: a behavioral switch hypothesisInflammation and insulin resistancePreadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation TherapyS6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2Inflammation, stress, and diabetesCentral role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouseB cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies"Control" laboratory rodents are metabolically morbid: why it mattersFat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolismChronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistanceThe ancient drug salicylate directly activates AMP-activated protein kinaseMolecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunctionTranscription factor 7-like 2 polymorphism and colon cancerThe protein kinase IKKepsilon regulates energy balance in obese miceAn inflammatory cascade leading to hyperresistinemia in humansData-mining analysis suggests an epigenetic pathogenesis for type 2 diabetes.Prevalence, predisposition and prevention of type II diabetes.Is the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritisMetabolic Inflammation-Differential Modulation by Dietary ConstituentsRoles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic ApproachesAdipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic DisordersObesity and cancer, a case for insulin signalingType-2 diabetes: Current understanding and future perspectivesInsulin receptor signaling in normal and insulin-resistant statesNutritional modulation of insulin resistanceReactive oxygen species in health and diseaseDoes inflammation determine whether obesity is metabolically healthy or unhealthy? The aging perspectiveTargeting inflammation in diabetes: Newer therapeutic optionsSomething old, something new and something very old: drugs for treating type 2 diabetesInflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targetsIL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease ProgressionThe immune system as a sensor of the metabolic stateRegulation of stem cell differentiation in adipose tissue by chronic inflammationMyeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistanceSTEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?Molecular mechanisms of insulin resistance in chronic hepatitis CImplication of inflammatory signaling pathways in obesity-induced insulin resistanceConditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistanceAspirin inhibits serine phosphorylation of insulin receptor substrate 1 in growth hormone treated animals
P2860
Q21136177-7637861C-E22A-4FAB-8006-8829D2D7496EQ21283908-39C7A473-3F04-45DC-80F7-7FBA88A07C56Q22241893-EBB41206-C2B6-43D0-B2A5-40515809357FQ22299231-7B1F9D99-309E-4548-8C6C-838DB2698803Q24309036-36581E0B-2C80-4F7A-923D-B35774778AD9Q24523336-66C14FE6-374F-4BD2-96BB-49F81F13CF45Q24564225-5FAAC64C-57B2-4668-8B13-0E0BAA1AEBE0Q24598772-1482AC4C-B16E-41DE-B727-CBB5B8891045Q24599731-D77AD670-4B4C-4273-80BB-BA84D98AB1C4Q24608263-3880DA30-C6E8-4E4A-BC1A-DA390427198BQ24617743-0159B0C3-08E3-485B-A90C-20EA05D691A6Q24630758-D1690075-5FD8-44A7-B510-470B69F11EA9Q24632414-3A498D91-E94A-43B1-AAAE-B04F41636F33Q24654061-4F07128A-2BE0-4874-89E1-4947043ECD30Q24658201-45831949-9043-4D8D-BF02-95227A447B76Q24796813-7A113944-6BAA-494A-AB9C-B67E0E48A3DBQ24811670-CE6735ED-B5BA-4A29-8ECB-9A590D187D05Q24815863-CAEBA4ED-B020-4AF2-9FB2-A4FAFBF1ED7AQ26746659-32C68625-A09A-450B-B7AB-3B43EACC0885Q26748868-4B77B073-3835-4C7C-B540-37EE9E0B5CEEQ26752576-44056DEB-327E-4D48-A75A-AC4A4EC04ED8Q26752618-B3CA3664-904C-4515-89B4-3E5E34AF8EC1Q26771452-0CAA55B0-A3B7-4937-B5F4-4D4128B228DDQ26801324-D847DC9E-4EE2-4477-A0FA-3491722C6E33Q26823171-D944F6F9-1C70-462D-B09A-41CF1F0453DBQ26824738-59D226E6-40D3-4ECA-ABCC-6DA412E07E01Q26851203-3D5C62A0-96D2-40F9-933C-EBA4FFC9B4EEQ26852364-A44D1E68-2132-4E8E-A999-B4A4D298E930Q26852726-FAA8D627-9A49-4D14-A7CD-EFEFD8AF51B4Q26865663-5BD6A5A7-4CB6-43FF-BF1C-773B1E8D1A4AQ26866480-D95391FD-B04C-48B6-9919-F82C6A8FF3C4Q27025620-0EB04760-2791-408A-88CE-16AA4CE6B17AQ27026072-D26DE71F-235C-48DE-AEA9-6ADE320F8960Q27028193-A662A8D5-8475-4A3F-804A-5E6A6C475849Q27347641-728E17F5-3E2E-41B2-8012-355FEBF14470Q27478329-E0FF0EA5-6D09-40F7-B5B7-4350C0F727C6Q27489665-949A05E5-8726-4397-A7E6-FDE1472C71A1Q27500365-ADC98E95-BE7F-4467-8A91-C0E113185C30Q28167026-1B02FA67-75F1-4F53-B2A2-4BE39BE71132Q28176156-F61347F6-0BCD-47E4-920A-7CC2FEB67FBE
P2860
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta
description
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Science
@fr
artículu científicu espublizáu en 2001
@ast
im August 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 31 August 2001)
@en
vedecký článok (publikovaný 2001/08/31)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd op 2001/08/31)
@nl
наукова стаття, опублікована в серпні 2001
@uk
name
Reversal of obesity- and diet- ...... targeted disruption of Ikkbeta
@ast
Reversal of obesity- and diet- ...... targeted disruption of Ikkbeta
@en
Reversal of obesity- and diet- ...... targeted disruption of Ikkbeta
@nl
type
label
Reversal of obesity- and diet- ...... targeted disruption of Ikkbeta
@ast
Reversal of obesity- and diet- ...... targeted disruption of Ikkbeta
@en
Reversal of obesity- and diet- ...... targeted disruption of Ikkbeta
@nl
prefLabel
Reversal of obesity- and diet- ...... targeted disruption of Ikkbeta
@ast
Reversal of obesity- and diet- ...... targeted disruption of Ikkbeta
@en
Reversal of obesity- and diet- ...... targeted disruption of Ikkbeta
@nl
P2093
P3181
P356
P1433
P1476
Reversal of obesity- and diet- ...... targeted disruption of Ikkbeta
@en
P2093
N Konstantopoulos
S E Shoelson
P304
P3181
P356
10.1126/SCIENCE.1061620
P407
P577
2001-08-31T00:00:00Z